Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 1
1922 1
1926 1
1950 1
1952 1
1973 1
1974 3
1975 1
1976 2
1977 2
1978 5
1979 5
1980 5
1981 3
1982 2
1983 4
1984 6
1985 11
1986 10
1987 12
1988 12
1989 15
1990 17
1991 22
1992 25
1993 20
1994 26
1995 24
1996 23
1997 24
1998 39
1999 35
2000 16
2001 20
2002 10
2003 22
2004 15
2005 22
2006 17
2007 26
2008 27
2009 33
2010 35
2011 31
2012 35
2013 50
2014 80
2015 97
2016 110
2017 103
2018 111
2019 98
2020 102
2021 113
2022 83
2023 100
2024 108
2025 61

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,757 results

Results by year

Filters applied: . Clear all
Page 1
FGFR Inhibition in Urothelial Carcinoma.
Li R, Linscott J, Catto JWF, Daneshmand S, Faltas BM, Kamat AM, Meeks JJ, Necchi A, Pradere B, Ross JS, van der Heijden MS, van Rhijn BWG, Loriot Y. Li R, et al. Among authors: ross js. Eur Urol. 2025 Feb;87(2):110-122. doi: 10.1016/j.eururo.2024.09.012. Epub 2024 Sep 30. Eur Urol. 2025. PMID: 39353825 Review.
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Pozdeyev N, Gay LM, Sokol ES, Hartmaier R, Deaver KE, Davis S, French JD, Borre PV, LaBarbera DV, Tan AC, Schweppe RE, Fishbein L, Ross JS, Haugen BR, Bowles DW. Pozdeyev N, et al. Among authors: ross js. Clin Cancer Res. 2018 Jul 1;24(13):3059-3068. doi: 10.1158/1078-0432.CCR-18-0373. Epub 2018 Apr 3. Clin Cancer Res. 2018. PMID: 29615459 Free PMC article.
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
Chalmers ZR, Connelly CF, Fabrizio D, Gay L, Ali SM, Ennis R, Schrock A, Campbell B, Shlien A, Chmielecki J, Huang F, He Y, Sun J, Tabori U, Kennedy M, Lieber DS, Roels S, White J, Otto GA, Ross JS, Garraway L, Miller VA, Stephens PJ, Frampton GM. Chalmers ZR, et al. Among authors: ross js. Genome Med. 2017 Apr 19;9(1):34. doi: 10.1186/s13073-017-0424-2. Genome Med. 2017. PMID: 28420421 Free PMC article.
Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer.
Lin JJ, Zhu VW, Yoda S, Yeap BY, Schrock AB, Dagogo-Jack I, Jessop NA, Jiang GY, Le LP, Gowen K, Stephens PJ, Ross JS, Ali SM, Miller VA, Johnson ML, Lovly CM, Hata AN, Gainor JF, Iafrate AJ, Shaw AT, Ou SI. Lin JJ, et al. Among authors: ross js. J Clin Oncol. 2018 Apr 20;36(12):1199-1206. doi: 10.1200/JCO.2017.76.2294. Epub 2018 Jan 26. J Clin Oncol. 2018. PMID: 29373100 Free PMC article.
Reply.
Ranasinghe I, Parzynski CS, Searfoss R, Montague J, Lin Z, Allen J, Vender R, Bhat K, Ross JS, Bernheim S, Krumholz HM, Drye E. Ranasinghe I, et al. Among authors: ross js. Gastroenterology. 2016 May;150(5):1249-1251. doi: 10.1053/j.gastro.2016.03.031. Epub 2016 Mar 26. Gastroenterology. 2016. PMID: 27025674 No abstract available.
Imaging of Spine Trauma.
Shah LM, Ross JS. Shah LM, et al. Among authors: ross js. Neurosurgery. 2016 Nov;79(5):626-642. doi: 10.1227/NEU.0000000000001336. Neurosurgery. 2016. PMID: 27404215 Review.
Comprehensive Immunogenomic Profiling of IDH1-/2-Altered Cholangiocarcinoma.
Makawita S, Lee S, Kong E, Kwong LN, Abouelfetouh Z, Danner De Armas A, Xiao L, Murugesan K, Danziger N, Pavlick D, Korkut A, Ross JS, Javle M. Makawita S, et al. Among authors: ross js. JCO Precis Oncol. 2024 Mar;8:e2300544. doi: 10.1200/PO.23.00544. JCO Precis Oncol. 2024. PMID: 38547421 Free PMC article.
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab.
Lin DI, Quintanilha JCF, Danziger N, Lang L, Levitan D, Hayne C, Hiemenz MC, Smith DL, Albacker LA, Leibowitz J, Mata DA, Decker B, Lakis S, Patel NR, Graf RP, Elvin JA, Ross JS, Pattani V, Huang RSP, Wehn AK. Lin DI, et al. Among authors: ross js. NPJ Precis Oncol. 2024 Sep 14;8(1):204. doi: 10.1038/s41698-024-00679-7. NPJ Precis Oncol. 2024. PMID: 39277692 Free PMC article.
1,757 results